<DOC>
	<DOCNO>NCT02632149</DOCNO>
	<brief_summary>The purpose study evaluate clinical effectiveness PINS vagus nerve stimulatior child Lennox-Gastaut Syndrome .</brief_summary>
	<brief_title>Trial Assess Vagus Nerve Stimulation Therapy Children With Lennox-Gastaut Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Lennox Gastaut Syndrome</mesh_term>
	<criteria>1 . Age 314 year 2 . Lennox Gastaut syndrome diagnostic standard 3 . Regular drug treatment invalid 4 . Antiepileptic drug stability recent 3 month 5 . Good health except epilepsy 6 . Patients ( ) familyscould understand method sign inform consent 7 . Patients good compliance could complete postoperative followup . 1 . Results MRI remind epilepsy cause intracranial spaceoccupying lesion 2 . Had epileptic focus excision surgery corpus callosum 3 . The vagus nerve lesion damage 4 . Tumor , cardiopulmonary anomaly , progressive neurological disease , asthma， mental disease，peptic ulcer，diabetes Type 1，bad health etc , surgical contraindication 5 . Participated clinical drug test subject within three month 6 . The researcher think suitable participant '</criteria>
	<gender>All</gender>
	<minimum_age>3 Years</minimum_age>
	<maximum_age>14 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>PINS Vagus Nerve Stimulator</keyword>
</DOC>